Search

everythinglearnresearchcommunity

for

Search:↓

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

COVID-19 infection is highly related to increased hair loss, especially in women.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Topical Minoxidil is effective for hair loss after COVID-19.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

The pandemic increased stress-related skin conditions and those affected by behavior changes.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.